Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nutex Health (NUTX) EBIT (2016 - 2025)

Historic EBIT for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to $130.4 million.

  • Nutex Health's EBIT rose 124913.59% to $130.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $358.9 million, marking a year-over-year increase of 378766.26%. This contributed to the annual value of $130.7 million for FY2024, which is 51133.89% up from last year.
  • According to the latest figures from Q3 2025, Nutex Health's EBIT is $130.4 million, which was up 124913.59% from $33.7 million recorded in Q2 2025.
  • In the past 5 years, Nutex Health's EBIT registered a high of $130.4 million during Q3 2025, and its lowest value of -$428.7 million during Q3 2022.
  • Its 5-year average for EBIT is $2.7 million, with a median of $5.3 million in 2024.
  • Its EBIT has fluctuated over the past 5 years, first crashed by 67569.8% in 2022, then soared by 546282.76% in 2025.
  • Nutex Health's EBIT (Quarter) stood at $15.5 million in 2021, then tumbled by 137.19% to -$5.8 million in 2022, then plummeted by 352.42% to -$26.1 million in 2023, then soared by 536.83% to $114.2 million in 2024, then grew by 14.15% to $130.4 million in 2025.
  • Its EBIT was $130.4 million in Q3 2025, compared to $33.7 million in Q2 2025 and $80.7 million in Q1 2025.